<head>
    <title>Wikinotes</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/semantic-ui/2.0.0/semantic.min.css" />
    <link rel="stylesheet" href="/static/styles.css" />
    <meta name="viewport" content="width=device-width">
    
<script type="text/javascript"
        src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>
<script type="text/x-mathjax-config">
MathJax.Hub.Config({
    TeX: {
        extensions: ['cancel.js']
    },
    tex2jax: {
        inlineMath: [  ['$', '$'] ],
        processEscapes: true
    }
});
</script>

</head>
<body>
    
    <div id="header" class="ui container">
        <a href="/">
            <img src="/static/img/logo-header.png" class="ui image" />
        </a>
    </div>
    
    <div id="content">
        <div class="ui container">
            
<div class="ui container">
    <div class="ui secondary segment">
        <div class="ui large breadcrumb">
            <a class="section" href="/">Home</a>
            <i class="right chevron icon divider"></i>
            <a class="section" href="/ANAT_322/">
                ANAT 322
            </a>
            <i class="right chevron icon divider"></i>
            <span class="active section">
                
                Monday, March 12, 2012
                
            </span>
        </div>
    </div>
    <h1 class="ui header">
        <div class="content">
            
            Monday, March 12, 2012
            
            <span>
                <a href="http://creativecommons.org/licenses/by-nc/3.0/">
                    <img src="/static/img/cc-by-nc.png" alt="CC-BY-NC"
                         title="Available under a Creative Commons Attribution-NonCommercial 3.0 Unported License" />
                </a>
            </span>
            
            <div class="sub header">
                Prolactin&#x27;s Biological Functions
            </div>
            
        </div>
    </h1>
    <div class="ui icon list">
        <div class="item">
            <i class="user icon"></i>
            <div class="content">
                <strong>Maintainer:</strong> admin
            </div>
        </div>
    </div>
    <div class="ui divider"></div>
    <div id="wiki-content">
	
        <h2 class="header"><i>1</i>Prolactin (PRL) Basics<a class="headerlink" href="#prolactin-prl-basics" name="prolactin-prl-basics">&para;</a></h2>
<h3 class="header"><i>1.1</i>Structure<a class="headerlink" href="#structure" name="structure">&para;</a></h3>
<ul>
<li>there are structural variants. heterogeniety</li>
<li>residual modification <ul>
<li>usually decrease activitity of PRL </li>
<li>glycosylated, phosphorylated, sulfated PRL</li>
<li>post translational </li>
<li>modification on residue differs among species</li>
</ul>
</li>
<li>cleaved forms:    <ul>
<li>16kDa and 8kDa (loop is destroyed)<ul>
<li>cathepsin D-like protease does this. </li>
<li>it's a antiangeogenic factor</li>
</ul>
</li>
<li>22kDa. C-terminal s-s loop removed<ul>
<li>by kallikren, a trypsin like serine protease</li>
<li>not well studied </li>
</ul>
</li>
</ul>
</li>
<li>native PRL: has a loop formed by disulfide bridge.</li>
</ul>
<h3 class="header"><i>1.2</i>synthesis and secretion<a class="headerlink" href="#synthesis-and-secretion" name="synthesis-and-secretion">&para;</a></h3>
<ul>
<li>produced by lactotrophs:  <ul>
<li>comprise 20-50% of anterior pituitary cells, depending on the physiological state <ul>
<li>50% when it's lactation phase for the organism</li>
</ul>
</li>
<li>also the last anterior pituitary cells to differenaite</li>
<li>adulthood prolactinomas: robust proliferative response.<ul>
<li>no other pituitary adenomas produce the same effect</li>
</ul>
</li>
<li>regulated by Pit1 (a transcription factor) </li>
</ul>
</li>
<li>PRL are also expressed in extrapituitary (periphery) sites<ul>
<li>ex: brain, thymus, lymph node, endometrium, mammary glands</li>
<li>they act as local growth factor and hormone. </li>
<li>account for ~20% of prolactin production </li>
</ul>
</li>
</ul>
<h3 class="header"><i>1.3</i>Regulation<a class="headerlink" href="#regulation" name="regulation">&para;</a></h3>
<ul>
<li>tonically inhibited by dopamine coming from hypothalamus </li>
</ul>
<h4 class="header"><i>1.3.1</i>Hypothaalmus-pituitary axis<a class="headerlink" href="#hypothaalmus-pituitary-axis" name="hypothaalmus-pituitary-axis">&para;</a></h4>
<ul>
<li>hypothalamus controls ant. pituitary<ul>
<li>hypophyseal portal artery branches into ME by primary plexus where many neurotransmitter/neuro peptides are released into.</li>
<li>secondary plexus then dumps into secondary plexus</li>
<li>tight control of hypothalamus over pitutiary because only a small amount needs to be secreted to affect pituiary  (direct access instead of being diluted by systemic blood) </li>
</ul>
</li>
<li>PRL is tonically inhibited by hypothalamus. Evidences: <ul>
<li>PRL level increase when pituitary is detached and placed somewhere else like on top of adrenal gland. </li>
<li>stalk transection also leads to increase in PRL</li>
<li>lesioning of the ME also increases PRL. </li>
<li>(basically any interruption and disconnection)</li>
<li>reglulated by dopamine (inhibitor) </li>
</ul>
</li>
</ul>
<h4 class="header"><i>1.3.2</i>Dopamine<a class="headerlink" href="#dopamine" name="dopamine">&para;</a></h4>
<ul>
<li>dopamin is converted from tyrosine by tyrosine hydroxylase and DOPA decarboxylase <ul>
<li>rate-limiting enzyme: tyrosine hydroxylase</li>
</ul>
</li>
<li>DA-nergic neurons:    <ul>
<li>TIDA : tuberoinfundibular dopaminergic neurons <ul>
<li>to ME when primary pelxus is </li>
</ul>
</li>
<li>THDA and DOPA: to short portal vessel</li>
</ul>
</li>
<li>lactotrophs have DA receptors<ul>
<li>in portal blood 80% of receptors are occupied</li>
<li>degree of inhibition of PRL release coorelates with degree of receptor occupancy </li>
</ul>
</li>
<li>DA agonists make PRL decrease. DA antagonists make PRL increase. </li>
<li>suckling leads to decrease in DA and consequently increase in PRL</li>
</ul>
<h4 class="header"><i>1.3.3</i>prolactin short feedback<a class="headerlink" href="#prolactin-short-feedback" name="prolactin-short-feedback">&para;</a></h4>
<ul>
<li>there's a negative feedback loop at ME or CNS. <ul>
<li>prlactin gains access to CSF </li>
<li>stimulation on DA neruons, which have PRLR (prolactin receptor)</li>
<li>PRLR K mice have 30-100 fold increase in PRL.</li>
</ul>
</li>
<li>feedback loop dimishes during lactation.</li>
</ul>
<h4 class="header"><i>1.3.4</i>Lactation<a class="headerlink" href="#lactation" name="lactation">&para;</a></h4>
<ul>
<li>Suckling leads to :  <ul>
<li>increase in secretion of opiod peptide, endorphin in arcuate nucleus --&gt; suppression of TIDA</li>
<li>dimished feedback control</li>
<li>increase in PRL release factors in hypothalamus<ul>
<li>TRH, VIP, oxytocin, neuropeptide Y, neurotensin, histamine</li>
</ul>
</li>
<li>release of adrenocorticotropin --&gt; more glucocorticoids released into the blood. </li>
<li>increase in number of lactotrophs (~50% of ant. pitutiary cells)</li>
<li>suppression of tyrosine hydorxylase (the rate limiting enzyme of DA synthesis) </li>
</ul>
</li>
</ul>
<h2 class="header"><i>2</i>Functions<a class="headerlink" href="#functions" name="functions">&para;</a></h2>
<ul>
<li>(has ~85 functions)  Main outline: </li>
</ul>
<h3 class="header"><i>2.1</i>reproudction<a class="headerlink" href="#reproudction" name="reproudction">&para;</a></h3>
<ul>
<li>lactation<ul>
<li>alveolar growth</li>
<li>milk protein synthesis </li>
</ul>
</li>
<li>luteotrophic function<ul>
<li>increase progesterone synthesis <ul>
<li>also inhibit progesterone degradation </li>
</ul>
</li>
<li>potentiate sterodogenic effects of LH (lutenizing hormone)</li>
<li>PRLR KO : infertile, lack normal luteal function, decrease ovulation, aberrant oogenesis, implantation failure<ul>
<li>restored by giving progesterone </li>
</ul>
</li>
</ul>
</li>
<li>parental behavior<ul>
<li>nest building, nursing, etc. </li>
<li>PRLR KO female mice can't recognize pups (so PRL also has effects on nervous system)</li>
</ul>
</li>
</ul>
<h3 class="header"><i>2.2</i>homeostasis<a class="headerlink" href="#homeostasis" name="homeostasis">&para;</a></h3>
<ul>
<li>immune function<ul>
<li>restores thymic function in PRL-deficient dwardf mice (or Pit1-KO mice)</li>
<li>B and T cells have PRLR and PRL, suggesting autocrine and paracine functions of PRL</li>
<li>PRL potentiates IL2 mitogenic effects (mitosis-promoting) in T cells </li>
<li>PRL has overlapping functions with some pathways (may share signaling pathway with cytokines) because PRL KO mice do okay with their immune system. </li>
</ul>
</li>
<li>osmoregulation <ul>
<li>stimualtes solute movement for lactation<ul>
<li>uptake of amino acid and glucose by mammary epithelial cells</li>
<li>also promote sodium, potassium and water retention by acting on kidney. </li>
</ul>
</li>
</ul>
</li>
</ul>
<h2 class="header"><i>3</i>Mechanism of Functions<a class="headerlink" href="#mechanism-of-functions" name="mechanism-of-functions">&para;</a></h2>
<h3 class="header"><i>3.1</i>Hormonal control of Lactogenesis<a class="headerlink" href="#hormonal-control-of-lactogenesis" name="hormonal-control-of-lactogenesis">&para;</a></h3>
<ul>
<li>estrogens act on lactotrophs to make them secrete PRL. </li>
<li>Progesterone inhibits lactogenesis (by inhibiting PRL)<ul>
<li>after baby is born, progesterone level drops sharply</li>
<li>this sharp decrease in progesterone accounts for initiation of lactation</li>
</ul>
</li>
<li>glucocorticoids or adrenocorticoropin (adrenal hormones) with PRL stimulates lactogenesis (synergistic) <ul>
<li>right after baby is born there's a sharp increase of glucocorticoids</li>
</ul>
</li>
<li>prolactin:    <ul>
<li>hypophysectomized mice don't make milk during pregnancy.<ul>
<li>treated with PRL will restore functions</li>
</ul>
</li>
<li>blocking of PRL surge before partuition by Da agonists inhibit lactogenesis</li>
<li>insulin, prolactin, hydrocortisol in combination induce cells to make milk proteins</li>
</ul>
</li>
</ul>
<h3 class="header"><i>3.2</i>Mammaroy Gland Development<a class="headerlink" href="#mammaroy-gland-development" name="mammaroy-gland-development">&para;</a></h3>
<ul>
<li>structure of alveolar:    <ul>
<li>lumen surrounded by a layer of epithelial cells, which secrete milk into the lumen</li>
<li>myoepithelai cells: muscles cells surrounded epithelial layer. contract upon oxytoxin stimulation --&gt;milk ejection </li>
</ul>
</li>
<li>prolactin <ul>
<li>stimulates differentiation of termianl end buds in virgin state<ul>
<li>..by acting through progesterone, which promotes differentiation</li>
</ul>
</li>
<li>growth and differentiation of alveoli in pregnancy </li>
</ul>
</li>
<li>during lactation, major cell type :alveoli </li>
<li>
<p>during involution, build up of milk in the gland initiates apoptosis of alveoli structure, which goes back to virgin-like state. </p>
</li>
<li>
<p>prolactin KO and PRLR KO have little terminal end buds </p>
<ul>
<li>adding prolactin wouldn't restore structure in PRLP KO <ul>
<li>because terminal end bud differentiation depends on indirect effect of PRL via progesterone.</li>
</ul>
</li>
</ul>
</li>
<li>PRLR partial KO have little alveolar growth/differentiation<ul>
<li>halfploid insufficiency </li>
<li>therefore PRL won't restore the function. you need the receptor!</li>
</ul>
</li>
</ul>
<h3 class="header"><i>3.3</i>Receptor Signaling Mechanism<a class="headerlink" href="#receptor-signaling-mechanism" name="receptor-signaling-mechanism">&para;</a></h3>
<ul>
<li>PRLR is a Class I cytokine receptor </li>
<li>prolactin receptor have many homologies with receptors in this family : like GH receptor, IL2 receptor, etc<ul>
<li>homologies include : Box1/2 (cytoplasm domain), disulfide bond, etc</li>
<li>act with JAK kinase, which interact with Box1/2 domains</li>
</ul>
</li>
<li>STAT: <ul>
<li>STAT is downstream of JAK. bind to JAK via SH2 domain</li>
<li>dimerize upon activation by JAK and go to nucleus to activate transcription via their TA domain (transcription activation)</li>
<li>There are 7 of them. Two of them are inhibitory (STAT4_beta and STAT1_beta)<ul>
<li>inhibit action when dimerize with other STAT </li>
</ul>
</li>
</ul>
</li>
<li>activation mechanisms<ul>
<li>JAK2 constitutively bind with PRLR via Box1. </li>
<li>activated receptor goes through confirmation change. they dimerzie and allow JAK to phosphorylate (thereby activate) each other</li>
<li>activated JAK2 recruits STAT and activate them</li>
<li>STAT dimerize and go into nucleus</li>
<li>STATs are also target of other pathways</li>
</ul>
</li>
<li>experiment show tha tEGF don't activate JAK2 like PRL do<ul>
<li>STAT5a is also not as upregulated when EGF is added. </li>
</ul>
</li>
<li>JAK KO shows no terminal bud differentiation and has little alveolar structure. </li>
<li>Prolactin mainly activates JAK@ and STAT5, esp. in mammary gland. but cytokine can activate some pathways of prolactin (--&gt;signal complexity&amp;redundancy)</li>
<li>gain of function of JAK (with mutation at JH2) leads to lukemia : myeloproliferative disorders</li>
<li>STAT protein is also targets fr many other tyrosine kinase:   <ul>
<li>ex: target for SAR kinase, which plays a big role in tumoergenesis and metatesis as well. </li>
</ul>
</li>
</ul>
<h2 class="header"><i>4</i>Breast Cancer and Prolactin<a class="headerlink" href="#breast-cancer-and-prolactin" name="breast-cancer-and-prolactin">&para;</a></h2>
<ul>
<li>statistics show that women who breast feed have less chance of getting breast cancer<ul>
<li>mostly those who breast feed for longer than 6 months get this protection of PRL.</li>
</ul>
</li>
<li>therefore, even though prolactin is a growth factor for mammary cells, it promotes differentiation --&gt; anticancer/antiproliferative<ul>
<li>highly differentiated and polarized cells are less likely to turn into cancer cells</li>
<li>prolactin makes epithelial cells highly diffentiate (to make milk proteins) and polarized (to transport milk proteins to lumen)<ul>
<li>factor that induces polarization is cancer-suppressing</li>
<li>polariztion comes with tight junction and adhesion molecules  <ul>
<li>PRL KO mice's mammary gland shows little staining of tight junction </li>
<li>blocking of JAK2 leads to loose structure. cells become more flat and loosely attached to each other due to less expression of adhesion molecule (Ecad)</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>therefore, dual role of PRL in breast carcinogenesis: <ul>
<li>growth and differentiation</li>
<li>suppressor/anti-metastasis activity</li>
</ul>
</li>
</ul>
	
    </div>
</div>

        </div>
    </div>
    <div id="footer" class="ui container">
        <div class="ui stackable grid">
            <div class="twelve wide column">
                <p>
                    Built by <a href="https://twitter.com/dellsystem">
                    @dellsystem</a>. Content is student-generated. <a
                    href="https://github.com/dellsystem/wikinotes">See the old codebase on GitHub</a>
                </p>
            </div>
            <div class="four wide right aligned column">
                <p><a href="#header">Back to top</a></p>
            </div>
        </div>
    </div>
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-28456804-1', 'auto');
  ga('send', 'pageview');

</script>
</body>
</html>
